当前位置: X-MOL 学术Aliment. Pharm. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Letter: evaluation and proposed reclassification of HCC prediction model of Tahata et al. in chronic hepatitis C genotype 4 patient. Authors’ reply
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-12-30 , DOI: 10.1111/apt.16721
Yuki Tahata 1 , Ryotaro Sakamori 1 , Ryoko Yamada 1 , Takahiro Kodama 1 , Hayato Hikita 1 , Hideki Hagiwara 2 , Yasuharu Imai 3 , Naoki Hiramatsu 4 , Shinji Tamura 5 , Keiji Yamamoto 6 , Masahide Oshita 7 , Kazuyoshi Ohkawa 8 , Taizo Hijioka 9 , Hiroyuki Fukui 10 , Toshifumi Ito 11 , Yoshinori Doi 12 , Yukinori Yamada 13 , Takayuki Yakushijin 14 , Yuichi Yoshida 15 , Tomohide Tatsumi 1 , Tetsuo Takehara 1 ,
Affiliation  

This article is linked to Tahata et al papers. To view these articles, visit https://doi.org/10.1111/apt.16632 and https://doi.org/10.1111/apt.16704

中文翻译:

信函:Tahata 等人的 HCC 预测模型的评估和重新分类建议。在慢性丙型肝炎基因型 4 患者中。作者的回复

本文链接到 Tahata 等人的论文。要查看这些文章,请访问 https://doi.org/10.1111/apt.16632 和 https://doi.org/10.1111/apt.16704
更新日期:2021-12-31
down
wechat
bug